
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity
Gianni Gori Savellini, Gabriele Anichini, Claudia Gandolfo, et al.
Viruses (2021) Vol. 13, Iss. 8, pp. 1439-1439
Open Access | Times Cited: 61
Gianni Gori Savellini, Gabriele Anichini, Claudia Gandolfo, et al.
Viruses (2021) Vol. 13, Iss. 8, pp. 1439-1439
Open Access | Times Cited: 61
Showing 1-25 of 61 citing articles:
Innate immune evasion strategies of SARS-CoV-2
Judith M. Minkoff, Benjamin R. tenOever
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 159
Judith M. Minkoff, Benjamin R. tenOever
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 159
SARS-CoV-2 biology and host interactions
Silvio Steiner, Annika Kratzel, G. Tuba Barut, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 4, pp. 206-225
Closed Access | Times Cited: 74
Silvio Steiner, Annika Kratzel, G. Tuba Barut, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 4, pp. 206-225
Closed Access | Times Cited: 74
Signaling mechanisms of SARS-CoV-2 Nucleocapsid protein in viral infection, cell death and inflammation
Wenbiao Wang, Junzhe Chen, Xueqing Yu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4704-4713
Open Access | Times Cited: 47
Wenbiao Wang, Junzhe Chen, Xueqing Yu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4704-4713
Open Access | Times Cited: 47
SARS‐CoV‐2 NSP7 inhibits type I and III IFN production by targeting the RIG‐I/MDA5, TRIF, and STING signaling pathways
Jian Deng, Yi Zheng, Shengnan Zheng, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Closed Access | Times Cited: 26
Jian Deng, Yi Zheng, Shengnan Zheng, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Closed Access | Times Cited: 26
Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19
R. K. Subbarao Malireddi, Bhesh Raj Sharma, Thirumala‐Devi Kanneganti
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 615-645
Closed Access | Times Cited: 8
R. K. Subbarao Malireddi, Bhesh Raj Sharma, Thirumala‐Devi Kanneganti
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 615-645
Closed Access | Times Cited: 8
Viral strategies to antagonize the host antiviral innate immunity: an indispensable research direction for emerging virus-host interactions
Na Chen, Jiayu Jin, Baoge Zhang, et al.
Emerging Microbes & Infections (2024)
Open Access | Times Cited: 7
Na Chen, Jiayu Jin, Baoge Zhang, et al.
Emerging Microbes & Infections (2024)
Open Access | Times Cited: 7
Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options
Mariem Znaidia, Caroline Demeret, Sylvie van der Werf, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1247-1247
Open Access | Times Cited: 36
Mariem Znaidia, Caroline Demeret, Sylvie van der Werf, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1247-1247
Open Access | Times Cited: 36
The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development
Haiyun Yu, Fei Guan, Heather Miller, et al.
Emerging Microbes & Infections (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 29
Haiyun Yu, Fei Guan, Heather Miller, et al.
Emerging Microbes & Infections (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 29
RIG-I-like receptors: Molecular mechanism of activation and signaling
Jie Zheng, Wenjia Shi, Ziqun Yang, et al.
Advances in immunology (2023), pp. 1-74
Closed Access | Times Cited: 20
Jie Zheng, Wenjia Shi, Ziqun Yang, et al.
Advances in immunology (2023), pp. 1-74
Closed Access | Times Cited: 20
Type I and type III interferons: From basic biology and genetics to clinical development for COVID-19 and beyond
Evangelos Andreakos
Seminars in Immunology (2024) Vol. 72, pp. 101863-101863
Closed Access | Times Cited: 5
Evangelos Andreakos
Seminars in Immunology (2024) Vol. 72, pp. 101863-101863
Closed Access | Times Cited: 5
The Key to Increase Immunogenicity of Next-Generation COVID-19 Vaccines Lies in the Inclusion of the SARS-CoV-2 Nucleocapsid Protein
Noe Juvenal Mendoza-Ramírez, Julio García‐Cordero, Gaurav Shrivastava, et al.
Journal of Immunology Research (2024) Vol. 2024, pp. 1-18
Open Access | Times Cited: 5
Noe Juvenal Mendoza-Ramírez, Julio García‐Cordero, Gaurav Shrivastava, et al.
Journal of Immunology Research (2024) Vol. 2024, pp. 1-18
Open Access | Times Cited: 5
Transcription Kinetics in the Coronavirus Life Cycle
Katarzyna Grelewska‐Nowotko, Ahmed Eısa Elhag, Tomasz W. Turowski
Wiley Interdisciplinary Reviews - RNA (2025) Vol. 16, Iss. 1
Open Access
Katarzyna Grelewska‐Nowotko, Ahmed Eısa Elhag, Tomasz W. Turowski
Wiley Interdisciplinary Reviews - RNA (2025) Vol. 16, Iss. 1
Open Access
TRIM25: A Global Player of Cell Death Pathways and Promising Target of Tumor-Sensitizing Therapies
W. Eberhardt, Usman Nasrullah, Josef Pfeilschifter
Cells (2025) Vol. 14, Iss. 2, pp. 65-65
Open Access
W. Eberhardt, Usman Nasrullah, Josef Pfeilschifter
Cells (2025) Vol. 14, Iss. 2, pp. 65-65
Open Access
Innate immune evasion and general host shutoff strategies of human respiratory RNA viruses
Juliette Bougon, Denys A. Khaperskyy
Future Virology (2025), pp. 1-17
Closed Access
Juliette Bougon, Denys A. Khaperskyy
Future Virology (2025), pp. 1-17
Closed Access
The structural basis of TRIM25-mediated regulation of RIG-I
Yunlong Li, Siqi Wu, Xuyang Tian, et al.
Journal of Biological Chemistry (2025), pp. 108367-108367
Open Access
Yunlong Li, Siqi Wu, Xuyang Tian, et al.
Journal of Biological Chemistry (2025), pp. 108367-108367
Open Access
Anti-interferon armamentarium of human coronaviruses
Oyahida Khatun, Sumandeep Kaur, Shashank Tripathi
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Oyahida Khatun, Sumandeep Kaur, Shashank Tripathi
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Interferon Regulatory Factor 3 Exacerbates the Severity of COVID-19 in Mice
Wendy E. Walker, Luiz F. Garcia, Pedro M. Palermo, et al.
Critical Care Explorations (2025) Vol. 7, Iss. 3, pp. e1225-e1225
Open Access
Wendy E. Walker, Luiz F. Garcia, Pedro M. Palermo, et al.
Critical Care Explorations (2025) Vol. 7, Iss. 3, pp. e1225-e1225
Open Access
All hands on deck: SARS-CoV-2 proteins that block early anti-viral interferon responses
Alessandra C. Setaro, Marta Gaglia
Current Research in Virological Science (2021) Vol. 2, pp. 100015-100015
Open Access | Times Cited: 39
Alessandra C. Setaro, Marta Gaglia
Current Research in Virological Science (2021) Vol. 2, pp. 100015-100015
Open Access | Times Cited: 39
SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways
Soo Jin Oh, Ok Sarah Shin
The Journal of Microbiology (2022) Vol. 60, Iss. 3, pp. 290-299
Open Access | Times Cited: 23
Soo Jin Oh, Ok Sarah Shin
The Journal of Microbiology (2022) Vol. 60, Iss. 3, pp. 290-299
Open Access | Times Cited: 23
Human coronaviruses disassemble processing bodies
Mariel Kleer, Rory P. Mulloy, Carolyn-Ann Robinson, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 8, pp. e1010724-e1010724
Open Access | Times Cited: 22
Mariel Kleer, Rory P. Mulloy, Carolyn-Ann Robinson, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 8, pp. e1010724-e1010724
Open Access | Times Cited: 22
SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells
Gianni Gori Savellini, Gabriele Anichini, Maria Grazia Cusi
Virus Research (2023) Vol. 332, pp. 199134-199134
Open Access | Times Cited: 13
Gianni Gori Savellini, Gabriele Anichini, Maria Grazia Cusi
Virus Research (2023) Vol. 332, pp. 199134-199134
Open Access | Times Cited: 13
Immunological mechanisms of the nucleocapsid protein in COVID-19
Fahime Edalat, Niloofar Khakpour, H. Heli, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Fahime Edalat, Niloofar Khakpour, H. Heli, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Swine acute diarrhea syndrome coronavirus nucleocapsid protein antagonizes the IFN response through inhibiting TRIM25 oligomerization and functional activation of RIG-I/TRIM25
Jiyu Zhang, Hongyan Shi, Liaoyuan Zhang, et al.
Veterinary Research (2024) Vol. 55, Iss. 1
Open Access | Times Cited: 4
Jiyu Zhang, Hongyan Shi, Liaoyuan Zhang, et al.
Veterinary Research (2024) Vol. 55, Iss. 1
Open Access | Times Cited: 4
PEDV nucleocapsid antagonizes zinc-finger antiviral protein by disrupting the interaction with its obligate co-factor, TRIM25
Jantakarn Chuenchat, Supasek Kardkarnklai, Jaraspim Narkpuk, et al.
Veterinary Microbiology (2024) Vol. 291, pp. 110033-110033
Closed Access | Times Cited: 3
Jantakarn Chuenchat, Supasek Kardkarnklai, Jaraspim Narkpuk, et al.
Veterinary Microbiology (2024) Vol. 291, pp. 110033-110033
Closed Access | Times Cited: 3
Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion
Gianni Gori Savellini, Gabriele Anichini, Claudia Gandolfo, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1273-1273
Open Access | Times Cited: 14
Gianni Gori Savellini, Gabriele Anichini, Claudia Gandolfo, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1273-1273
Open Access | Times Cited: 14